Boston Scientific Corp (BSX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.97B
As of 2025-12-31
$539.00M
As of 2026-06-30
+28.4%
3-year compound annual growth
+2.5%
5-year compound annual growth
+19.9%
10-year compound annual growth
2007-12-31: $1.45B2008-12-31: $1.64B2009-12-31: $864.00M2010-12-31: $213.00M2011-12-31: $267.00M2012-12-31: $207.00M2013-12-31: $217.00M2014-12-31: $587.00M2015-12-31: $319.00M2016-12-31: $196.00M2017-12-31: $188.00M2018-12-31: $146.00M2019-12-31: $217.00M2020-12-31: $1.73B2021-12-31: $1.93B2022-12-31: $928.00M2023-12-31: $865.00M2024-12-31: $414.00M2025-12-31: $1.97B$1.97B
2007-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$1.97B+374.6%2026-02-17, Balance as of period end
2024-12-31$414.00M-52.1%2026-02-17, Balance as of period end
2023-12-31$865.00M-6.8%2026-02-17, Balance as of period end
2022-12-31$928.00M-51.8%2025-02-18, Balance as of period end
2021-12-31$1.93B+11.0%2024-02-20, Balance as of period end
2020-12-31$1.73B+699.1%2023-02-23, Balance as of period end
2019-12-31$217.00M+48.6%2022-02-23, Balance as of period end
2018-12-31$146.00M-22.3%2021-02-23, Balance as of period end
2017-12-31$188.00M-4.1%2020-02-25, Balance as of period end
2016-12-31$196.00M-38.6%2019-02-19, Balance as of period end
2015-12-31$319.00M-45.7%2018-02-20, Balance as of period end
2014-12-31$587.00M+170.5%2017-02-23, Balance as of period end
2013-12-31$217.00M+4.8%2016-02-24, Balance as of period end
2012-12-31$207.00M-22.5%2015-02-25, Balance as of period end
2011-12-31$267.00M+25.4%2014-02-26, Balance as of period end
2010-12-31$213.00M-75.3%2013-02-22, Balance as of period end
2009-12-31$864.00M-47.3%2012-02-17, Balance as of period end
2008-12-31$1.64B+13.0%2011-02-17, Balance as of period end
2007-12-31$1.45Bn/a2010-02-26, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Boston Scientific Corp (BSX)2025-12-31$1.97B+374.6%
Becton Dickinson & Co (BDX)2025-09-30$641.00M-62.7%
Stryker Corp (SYK)2025-12-31$4.01B+9.8%
Medline Inc. (MDLN)2025-12-31$1.94B+874.4%
Baxter International Inc (BAX)2025-12-31$1.97B+11.5%
Solventum Corp (SOLV)2025-12-31$878.00M+15.2%
ResMed Inc (RMD)2026-06-30$1.47B+21.5%
Dexcom Inc (DXCM)2025-12-31$917.70M+51.4%
MiniMed Group, Inc. (MMED)2026-04-24$298.00Mn/m

Compare BSX, BDX, SYK, MDLN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗